Cullin 7 in tumor development: a novel potential anti-cancer target

Yumiao Li1, Aiming Zang1, Jiejun Fu2

  • 1Department of Medical Oncology, Affiliated Hospital of Hebei University, Hebei Key Laboratory of Cancer Radiotherapy and Chemotherapy, Baoding, Hebei, China.

Neoplasma
|February 23, 2021
PubMed

Insights

Cullin 7 (Cul7) is a scaffold protein crucial for cell growth and development. Mutations in Cul7 cause dwarfism, and its role as an oncogene in various cancers highlights its potential as an anti-cancer target.

Area of Science:

  • Molecular Biology
  • Oncology
  • Genetics

Background:

  • Cullin 7 (Cul7) functions as a scaffold protein in E3 ubiquitin ligase complexes, including SCF and CRL7SMU1.
  • Cul7 plays a vital role in cell growth, development, and regulation of key cellular processes like senescence and apoptosis.
  • Mutations in Cul7 are linked to 3-M dwarf syndrome and implicated in tumor development, suggesting its oncogenic potential.

Purpose of the Study:

  • To review the multifaceted roles of Cullin 7 (Cul7) in the development of malignant tumors.
  • To explore Cul7's involvement in oncogenic signaling pathways.
  • To discuss the therapeutic potential of targeting Cul7 in cancer treatment.

Main Methods:

  • Literature review of studies on Cullin 7 (Cul7) function.
  • Analysis of Cul7's role in various cancer types and signaling pathways.
  • Evaluation of Cul7 as a potential anti-cancer therapeutic target.

Main Results:

  • Cul7 is highly expressed in multiple cancers, including breast, lung, and hepatocellular carcinoma.
  • Cul7 promotes tumor development, cell transformation, and survival through regulation of protein degradation pathways.
  • Cul7's involvement in oncogenic signaling pathways is critical for its role in cancer progression.

Conclusions:

  • Cullin 7 (Cul7) is a significant factor in malignant tumor development and progression.
  • Targeting Cul7 presents a promising strategy for novel anti-cancer therapies.
  • Further research into Cul7's mechanisms could unlock new avenues for cancer treatment.

Related Concept Videos

Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.9K
Cancer-Critical Genes II: Tumor Suppressor Genes01:05

Cancer-Critical Genes II: Tumor Suppressor Genes

Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
8.6K
Loss of Tumor Suppressor Gene Functions01:12

Loss of Tumor Suppressor Gene Functions

Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
When the tumor suppressor genes develop mutations or are lost, cells start growing out of control, leading to cancer. However, a single functional copy of the tumor suppressor gene is enough for the cells to maintain their normal functions and cell...
5.4K
Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
5.3K
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
8.1K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
4.1K